Market Tracker

07/01 5:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

122.12
Delayed Data
As of 4:00pm ET
 +2.85 / +2.39%
Today’s Change
71.63
Today|||52-Week Range
131.84
+12.64%
Year-to-Date
3 Biotech Stocks to Buy on Sale Right Now
Jun 29 / MotleyFool.com - Paid Partner Content
7 Profitable Medical Stocks Ranked as Buys Now
Jun 21 / Zacks.com - Paid Partner Content
3 Healthcare Stocks That Are Looking Cheap
Jun 24 / MotleyFool.com - Paid Partner Content
7 Biotech Stocks that are Buys Right Now
Jun 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close119.27
Today’s open119.27
Day’s range119.02 - 122.77
Volume320,318
Average volume (3 months)383,423
Market cap$2.5B
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+2,064.46%
Earnings growth (this year)+1.78%
Earnings growth (next 5 years)+53.87%
Revenue growth (last year)+11.43%
P/E ratio10.1
Price/Sales32.00
Price/Book7.82

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co+0.49+1.46%
HZNPHorizon Pharma PLC+0.35+2.13%
GLPGGalapagos NV-0.61-1.10%
MYGNMyriad Genetics Inc+0.17+0.56%
Data as of 4:14pm ET, 07/01/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$71.9M
Annual profit (last year)$257.3M
Net profit margin357.80%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts